Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | Jan-16 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Jan-21 | Jan-22 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 2,692 | 2,495 | 2,350 | 2,239 | 2,274 | 1,791 | 2,415 | 2,685 | 2,243 | 1,755 | | 1,755 |
% Growth | NA | -7.3% | -5.8% | -4.7% | 1.5% | -21.2% | 34.8% | 11.2% | -16.5% | -21.8% | | |
| | | | | | | | | | | | |
Cost of Revenue | (1,637) | (1,526) | (1,427) | (1,318) | (1,350) | (1,056) | (1,385) | (1,614) | (1,370) | (974) | | (974) |
Gross Profit | 1,055 | 968 | 923 | 921 | 924 | 736 | 1,030 | 1,070 | 873 | 782 | | 782 |
% Revenue | 39.2% | 38.8% | 39.3% | 41.1% | 40.6% | 41.1% | 42.6% | 39.9% | 38.9% | 44.5% | | 44.5% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | (137) | (122) | (107) | 0 | (119) | (136) | (195) | (221) | (169) | (140) | | (140) |
General and Admin | (679) | (637) | (607) | (660) | (550) | (506) | (630) | (690) | (685) | (547) | | (547) |
Other Inc / (Exp) | (36) | (65) | (188) | (10) | (78) | (235) | (87) | (366) | (89) | 10 | | 10 |
Total Operating Exp | (852) | (823) | (902) | (669) | (748) | (876) | (912) | (1,276) | (943) | (677) | | (677) |
| | | | | | | | | | | | |
Operating Income | 203 | 145 | 22 | 252 | 176 | (141) | 118 | (206) | (71) | 104 | | 104 |
% Revenue | 7.5% | 5.8% | 0.9% | 11.2% | 7.7% | -7.8% | 4.9% | -7.7% | -3.2% | 5.9% | | 5.9% |
| | | | | | | | | | | | |
Interest Expense | (38) | (35) | (32) | (25) | (30) | (44) | (37) | (47) | (64) | (43) | | (43) |
Pre-tax Income | 165 | 111 | (11) | 227 | 146 | (184) | 80 | (253) | (134) | 62 | | 62 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (41) | (23) | 10 | (27) | (17) | 46 | (13) | 64 | 95 | (10) | | (10) |
Net Income to Company | 123 | 88 | (1) | 200 | 129 | (139) | 67 | (189) | (39) | 52 | | 52 |
% Margin | 4.6% | 3.5% | 0.0% | 8.9% | 5.7% | -7.7% | 2.8% | -7.0% | -1.7% | 2.9% | | 2.9% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (0) | 0 | 1 | (0) | (0) | 2 | 2 | 1 | (0) | (4) | | (4) |
Net Income to Stockholders | 123 | 88 | 0 | 200 | 129 | (137) | 69 | (188) | (40) | 48 | | 48 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | (3) | (2) | 0 | (8) | (3) | (1) | (1) | (1) | (1) | (2) | | (2) |
| | | | | | | | | | | | |
Net Income to Common | 120 | 86 | 0 | 193 | 126 | (138) | 68 | (189) | (40) | 46 | | 46 |
% Margin | 4.5% | 3.4% | 0.0% | 8.6% | 5.5% | -7.7% | 2.8% | -7.0% | -1.8% | 2.6% | | 2.6% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 1.22 | 0.90 | 0.00 | 2.07 | 1.48 | (1.70) | 0.82 | (2.37) | (0.51) | 0.58 | | 0.58 |
Diluted EPS (Continuing Ops) | 1.20 | 0.89 | 0.00 | 2.05 | 1.44 | (1.70) | 0.81 | (2.37) | (0.51) | 0.58 | | 0.58 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 98.60 | 95.30 | 93.70 | 93.00 | 85.10 | 81.00 | 82.30 | 79.70 | 79.40 | 80.00 | | 80.00 |
WA Diluted Shares Out. | 100.00 | 96.20 | 95.40 | 95.00 | 87.20 | 81.00 | 83.30 | 79.70 | 79.40 | 80.00 | | 80.00 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 165 | 111 | (11) | 227 | 146 | (184) | 80 | (253) | (134) | 62 | | 62 |
Addback: Net Interest Expense | 38 | 35 | 32 | 25 | 30 | 44 | 37 | 47 | 64 | 43 | | 43 |
Addback: Other Non Operating Expenses, Total | (3) | (4) | 2 | (6) | (5) | (4) | (3) | (7) | 5 | (1) | | (1) |
Addback: Depreciation & Amortization | 49 | 44 | 37 | 32 | 33 | 33 | 33 | 35 | 35 | 26 | | 26 |
Addback: Restructuring Charges | 38 | 50 | 82 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 222 | 0 | 48 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (90) | (90) | (9) | | (9) |
Addback: Asset Writedown | 0 | 0 | 69 | 0 | 0 | 0 | 0 | 380 | 185 | 9 | | 9 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 2 | 18 | 0 | 1 | 0 | 6 | 34 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 287 | 254 | 212 | 278 | 204 | 116 | 182 | 161 | 64 | 131 | | 131 |
% Margin | 10.7% | 10.2% | 9.0% | 12.4% | 9.0% | 6.5% | 7.5% | 6.0% | 2.9% | 7.4% | | 7.4% |
| | | | | | | | | | | | |
Adjusted EBIT | 239 | 210 | 174 | 246 | 171 | 83 | 149 | 126 | 29 | 104 | | 104 |
% Margin | 8.9% | 8.4% | 7.4% | 11.0% | 7.5% | 4.6% | 6.2% | 4.7% | 1.3% | 5.9% | | 5.9% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 123 | 88 | (1) | 200 | 129 | (139) | 67 | (189) | (39) | 52 | | 52 |
Addback: Unusual Items | 39 | 68 | 151 | 1 | 0 | 228 | 34 | 339 | 95 | 1 | | 1 |
Less: Tax Benefit of Unusual Items (26%) | (10) | (18) | (39) | (0) | 0 | (59) | (9) | (88) | (25) | (0) | | (0) |
Adjusted Net Income | 152 | 138 | 111 | 201 | 129 | 30 | 92 | 62 | 31 | 52 | | 52 |
% Margin | 5.7% | 5.5% | 4.7% | 9.0% | 5.7% | 1.7% | 3.8% | 2.3% | 1.4% | 3.0% | | 3.0% |